Dr. Gautam Borthakur, M.D.
Claim this profileMD Anderson Cancer Center
Expert in T-Lymphoblastic Leukemia/Lymphoma
Expert in Acute Myeloid Leukemia
16 reported clinical trials
28 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
Global LeaderN
KRAS
PTPN11
2Acute Myeloid Leukemia
Global LeaderFLT3 positive
N
KRAS
Affiliated Hospitals
Clinical Trials Gautam Borthakur, M.D. is currently running
CFI-400945 + Azacitidine
for Leukemia
The purpose of this study is to test the safety of an investigational drug called CFI-400945 alone and in combination with azacitidine.
Recruiting1 award Phase 1 & 2
Iadademstat + Gilteritinib
for Acute Myeloid Leukemia
Iadademstat is being studied as a treatment for subjects with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) with FMS-like tyrosine kinase mutation (FLT3 mut+). During the trial, iadademstat will be given in combination with gilteritinib, a drug that is already approved to treat patients with FLT3-mutated R/R AML.
Recruiting1 award Phase 1
More about Gautam Borthakur, M.D.
Clinical Trial Related7 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Gautam Borthakur, M.D. has experience with
- Azacitidine
- Venetoclax
- Decitabine
- Cytarabine
- Filgrastim-sndz
- Fludarabine Phosphate
Breakdown of trials Gautam Borthakur, M.D. has run
T-Lymphoblastic Leukemia/Lymphoma
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Myelodysplastic syndrome
Myeloid Leukemia
- Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Tamibarotene + Venetoclax/Azacitidine for Acute Myeloid Leukemia
- Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gautam Borthakur, M.D. specialize in?
Gautam Borthakur, M.D. focuses on T-Lymphoblastic Leukemia/Lymphoma and Acute Myeloid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved N patients, or patients who are KRAS.
Is Gautam Borthakur, M.D. currently recruiting for clinical trials?
Yes, Gautam Borthakur, M.D. is currently recruiting for 5 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Gautam Borthakur, M.D. has studied deeply?
Yes, Gautam Borthakur, M.D. has studied treatments such as Azacitidine, Venetoclax, Decitabine.
What is the best way to schedule an appointment with Gautam Borthakur, M.D.?
Apply for one of the trials that Gautam Borthakur, M.D. is conducting.
What is the office address of Gautam Borthakur, M.D.?
The office of Gautam Borthakur, M.D. is located at: MD Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.